GlassScriptPhysician profile
Michelle L Libretti
NPI 1609316595
$788.13
in general payments reported to CMS, 2019-2025
12 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $167 · 2023: $185 · 2024: $84.82 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $221.06 | 2021-2024 | Slynd |
| Astellas Pharma US INC | $95.10 | 2021-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $93.44 | 2025 | |
| Mayne Pharma Commercial LLC | $64.43 | 2023-2025 | |
| Millicent US INC | $56.40 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Pfizer INC. | $54.79 | 2021-2022 | |
| Mycovia Pharmaceuticals, INC. | $54.45 | 2022-2023 | Vivjoa |
| Hologic Sales and Service, LLC | $42.82 | 2021-2023 | Aptima |
| Exact Sciences Corporation | $39.40 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Agile Therapeutics, INC. | $27.59 | 2021-2024 | Twirla |
| Urovant Sciences INC | $23.32 | 2021 | |
| Therapeuticsmd, INC. | $15.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Libretti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.